Table of contents

  • Brand Names
  • Chemistry
  • Pharmacologic Category
  • Mechanism of Action
  • Therapeutic Use
  • Pregnancy and Lactation Implications
  • Contraindications
  • Warnings and Precautions
  • Adverse Reactions
  • Genes that may be involved
  • Drug Interactions
  • Dosage
  • Special Considerations

Brand Names


Greece: Anasteron, Oxybolone, Oxymetholone.

North America

USA: Anadrol.

Latin America

Brazil: Hemogenin.

Drug combinations


Oxymetholone: C~21~H~32~O~3~. Mw: 332.48. (1) Androstan-3-one, 17-hydroxy-2-(hydroxymethylene)-17-methyl-, (5α,17β)-; (2) 17β-Hydroxy-2-(hydroxymethylene)-17-methyl-5α-androstan-3-one. CAS-434-07-1 (1963).

Pharmacologic Category

Hematopoietic Agents. Anabolic Steroid. (ATC-Code: A14AA05).

Mechanism of action

Enhances production and urinary excretion of erythropoietin in anemias due to bone marrow failure. Stimulates erythropoiesis in anemias due to deficient red cell production.

Therapeutic use

Anemias caused by deficient red cell production.

Pregnancy and lactiation implications

Pregnancy should be avoided for 1 month following therapy. This drug may cause severe fetal defects. Oligospermia or amenorrhea may occur resulting in impairment of fertility. Excretion in breast milk unknown (not recommended in nursing women).

Unlabeled use


Hypersensitivity to oxymetholone or any component of the formulation. Breast cancer in men. Breast cancer in women with hypercalcemia. Prostate cancer. Severe liver dysfunction. Nephrosis. Pregnancy.

Warnings and precautions

Anabolic steroids may cause blood lipid changes with increased risk of arteriosclerosis. Use with caution in hepatic disease. May cause peliosis hepatis or liver cell tumors. Use with caution in breast cancer (may cause hypercalcemia by stimulating osteolysis), in diabetes mellitus, in conditions influenced by edema (may cause fluid retention), and in elderly patients (greater risk for prostatic hyperplasia, fluid retention, and transaminase elevations). May accelerate bone maturation without producing compensatory gain in linear growth in children. May cause mild virilization in women. May decrease thyroxine-binding globulin, T~4~, and increase resin uptake of T~3~ and T~4.~



Legal Notice
Privacy Policy
Cookie Policy


Phone: +34-981-780505
Email: genomicmedicine@wagem.org
Location: Sta Marta de, C. P. Babío, S/N, 15165 Bergondo, A Coruña

Copyright © 2023 WAGEM

Add to cart